Ingevity

US · NGVT #2634 by market cap Listed 1970

70.92 -1.88 -2.58%

Live - 5344 symbols - heartbeat 41s ago · 2026-10-07 20:02

After-hours 70.92 0.00%

Market cap: 2.44B
P/E (TTM): 46.66
P/B: 51.99
EPS: -4.61
Div yield: 0.00%
52W pos: 75%

Reader sentiment Are you bullish or bearish on NGVT?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Financial Health how this is computed

Fair

Altman Z-Score is 2.56, in the 1.8-3.0 "grey zone".
Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.

Revenue annual, last 8 years

Latest year -2.71% YoY

Margins

Gross margin: 39.53%
Operating margin: 22.43%
Net margin: -14.31%

Key ratios & quality

Enterprise value: 3.58B
Altman Z-Score: 2.56

Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.

Income statement

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	1.13B	1.29B	1.22B	1.39B	1.67B	1.22B	1.20B	1.17B
Gross profit	416.80M	482.00M	465.50M	512.80M	570.10M	445.00M	464.80M	461.50M
Selling & admin expenses	132.40M	163.10M	149.40M	179.30M	198.80M	161.80M	157.80M	171.20M
Research & development	21.50M	19.70M	22.60M	26.30M	30.30M	25.40M	24.50M	28.40M
Operating profit	262.90M	299.20M	293.50M	307.20M	341.00M	257.80M	282.50M	261.90M
Pretax profit	221.80M	227.90M	235.10M	162.80M	269.60M	130.00M	-140.50M	-142.10M
Tax	40.00M	44.20M	53.70M	44.70M	58.00M	24.20M	-19.10M	8.20M
Net profit	181.80M	183.70M	181.40M	118.10M	211.60M	-5.40M	-430.30M	-167.10M
Basic EPS	4	4	4	3	6	0	-12	-5
Diluted EPS	3.97	4.35	4.37	2.95	5.50	-0.15	-11.85	-4.61

Line item	2025-03	2025-06	2025-09	2025-12	2026-03	2026-06
Revenue	247.90M	331.50M	333.10M	255.10M	258.00M	314.10M
Gross profit	111.90M	127.80M	133.90M	87.80M	116.40M	139.00M
Selling & admin expenses	41.90M	43.60M	44.10M	41.60M	40.70M	39.00M
Research & development	7.00M	7.00M	7.00M	7.40M	6.70M	6.10M
Operating profit	63.00M	77.20M	82.80M	38.80M	69.00M	93.90M
Pretax profit	37.60M	-136.60M	62.20M	-105.40M	30.20M	50.70M
Tax	8.50M	4.80M	21.40M	-26.60M	6.80M	10.90M
Net profit	20.50M	-146.50M	43.50M	-84.60M	59.80M	35.30M
Basic EPS	1	-4	1	-2	2	1
Diluted EPS	0.56	-4.02	1.18	-2.37	1.66	1.00

Balance sheet

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Total current assets	422.70M	463.20M	628.70M	724.90M	683.30M	658.60M	493.20M	454.20M
Cash & ST investments	77.90M	56.50M	257.70M	275.40M	76.70M	95.90M	68.00M	78.10M
Inventory	191.40M	212.50M	189.00M	241.20M	335.00M	308.80M	195.90M	186.00M
Total assets	1.32B	2.14B	2.33B	2.47B	2.74B	2.62B	2.02B	1.65B
Total current liabilities	183.30M	215.50M	223.40M	268.90M	303.50M	362.90M	264.10M	341.30M
Short-term debt	11.20M	39.60M	42.20M	37.00M	17.40M	103.10M	75.70M	58.90M
Long-term debt	741.20M	1.23B	1.27B	1.25B	1.47B	1.38B	1.34B	1.16B
Total liabilities	976,500,000.00	1,610,900,000.00	1,692,400,000.00	1,795,200,000.00	2,038,200,000.00	1,991,900,000.00	1,827,400,000.00	1,621,400,000.00
Total equity	338.70M	530.80M	642.10M	673.80M	698.30M	631.40M	195.20M	29.70M
Retained earnings	313.50M	497.20M	678.00M	796.10M	1.01B	1.00B	572.00M	404.90M

Line item	2025-03	2025-06	2025-09	2025-12	2026-03	2026-06
Total current assets	530.00M	536.00M	522.20M	454.20M	581.80M	543.80M
Cash & ST investments	71.50M	76.90M	83.40M	78.10M	95.40M	97.40M
Inventory	245.40M	220.30M	193.70M	186.00M	203.60M	154.00M
Total assets	2.06B	1.88B	1.83B	1.65B	1.65B	1.54B
Total current liabilities	264.60M	393.10M	411.60M	341.30M	409.40M	337.60M
Short-term debt	76.20M	109.50M	112.10M	58.90M	135.20M	156.20M
Long-term debt	1.33B	1.24B	1.16B	1.16B	1.08B	1.06B
Total liabilities	1,821,500,000.00	1,757,000,000.00	1,695,700,000.00	1,621,400,000.00	1,611,300,000.00	1,490,600,000.00
Total equity	234.60M	120.70M	138.10M	29.70M	38.90M	46.90M
Retained earnings	592.50M	446.00M	489.50M	404.90M	464.70M	500.00M

Cash flow

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Operating cash flow	252.00M	275.70M	352.40M	293.30M	313.40M	205.10M	128.60M	331.20M
Depreciation & amortization	57.00M	85.00M	100.20M	109.90M	108.80M	122.80M	108.30M	106.40M
Free cash flow	158.10M	160.90M	246.50M	189.50M	170.90M	95.30M	51.00M	273.50M
Dividends paid	--	--	--	--	--	--	--	--
Stock buybacks / issuance	-47.40M	-6.40M	-88.00M	-109.40M	-145.20M	-92.10M	0	-56.30M
Ending cash balance	77.80M	64.60M	258.40M	280.70M	84.30M	111.90M	86.60M	112.60M

Line item	2025-03	2025-06	2025-09	2025-12	2026-03	2026-06
Operating cash flow	25.40M	79.00M	129.70M	97.10M	-2.00M	-13.80M
Depreciation & amortization	24.90M	25.60M	28.00M	27.90M	22.70M	22.00M
Free cash flow	15.40M	66.80M	117.80M	73.50M	-12.30M	-24.10M
Dividends paid	--	--	--	--	--	--
Stock buybacks / issuance	0	0	-25.20M	-31.10M	-52.30M	-34.50M
Ending cash balance	90.90M	107.10M	114.40M	112.60M	155.30M	180.90M

Returns & efficiency

Line item	2018	2019	2020	2021	2022	2023	2024	2025
ROE %	56.12	42.25	30.93	17.95	30.84	-0.81	-104.11	-148.60
ROA %	15.07	10.63	8.11	4.92	8.13	-0.20	-18.52	-9.10
ROIC %	21.40	15.14	11.20	7.67	12.03	2.88	-18.73	-7.51
5-year avg ROE %	36.74	38.24	41.00	42.40	35.62	24.23	-5.04	-40.95
EBIT margin %	22.49	21.85	23.21	15.44	19.86	4.92	-31.13	-5.57
FCF / sales %	13.95	12.44	20.27	13.60	10.23	5.63	3.63	23.42
Current ratio	2.31	2.15	2.81	2.70	2.25	1.81	1.87	1.33
Quick ratio	1.20	1.08	1.90	1.74	1.07	0.85	0.87	0.69
Debt / assets	57.21	60.92	57.58	53.59	55.94	58.50	71.64	75.27
LT debt / equity	218.84	238.34	202.79	190.89	216.71	226.70	703.53	3,985.86
Interest coverage	7.68	5.17	5.99	4.12	5.36	0.89	-4.48	-0.84
Revenue CAGR (3Y) %	5.76	12.49	7.74	7.07	8.87	-0.02	-4.81	-11.21
Net income CAGR (3Y) %	28.50	73.46	12.77	-11.28	4.83	--	--	--
FCF CAGR (3Y) %	--	31.23	26.52	6.22	2.03	-27.15	-35.44	16.97

Line item	2025-03	2025-06	2025-09	2025-12	2026-03	2026-06
ROE %	-88.14	-106.83	-37.38	-148.60	-93.46	64.44
ROA %	-15.31	-10.43	-3.26	-9.10	-6.90	3.16
ROIC %	-14.85	-8.51	0.21	-7.51	-5.84	6.96
5-year avg ROE %	--	--	--	--	--	--
EBIT margin %	-25.30	-11.61	-23.28	-5.57	-6.47	9.17
FCF / sales %	7.04	11.35	17.34	23.42	20.87	13.35
Current ratio	2.00	1.36	1.27	1.33	1.42	1.61
Quick ratio	0.89	0.69	0.61	0.69	0.60	0.75
Debt / assets	70.14	73.25	70.43	75.27	75.43	80.41
LT debt / equity	582.23	1,048.88	854.02	3,985.86	2,852.19	2,302.99
Interest coverage	-3.58	-1.69	-3.75	-0.84	-1.04	1.55
Revenue CAGR (3Y) %	--	--	--	--	--	--
Net income CAGR (3Y) %	--	--	--	--	--	--
FCF CAGR (3Y) %	--	--	--	--	--	--

✦ Quant Revenue Concentration how this is computed

Lead segment, long tail

Performance Materials (PM) is the largest reported line at 51.13% of revenue, across 3 reported segments.
Pavement Technologies (PT) follows at 33.17%, so the top line still matters most but isn’t the whole story.

Revenue breakdown most recent period

Business

Performance Materials (PM)51.13%

Pavement Technologies (PT)33.17%

Advanced Polymer Technologies (APT)15.70%

Quote time 2026-10-07 20:02:22 · For reference only, not investment advice and not tailored to your situation.